Heike Froehlich, Dr.
AbbVie Deutschland GmbH & Co. KG
Mainzer Straße 81
Wiesbaden
Germany
65189
Papers:
2E-1
LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF DIFFERENT ANTIVIRAL TREATMENTS FOR CHRONIC GENOTYPE-1 HCV INFECTION IN GERMANY INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR